{"id":"W3133576337","doi":"10.1200/jco.2021.39.6_suppl.12","title":"CheckMate 9KD Arm B final analysis: Efficacy and safety of nivolumab plus docetaxel for chemotherapy-naïve metastatic castration-resistant prostate cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Enzalutamide; Docetaxel; Prostate cancer; Internal medicine; Nivolumab; Oncology; Abiraterone acetate; Chemotherapy; Cancer; Prednisone; Androgen deprivation therapy; Immunotherapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002387743,0.001193086,0.001366621,0.0006151473,0.0002741424,0.001409623,0.0008357761,0.001145669,0.007959607],"category_scores_gemma":[0.001689365,0.0003899884,0.002507248,0.0004338789,0.0003943874,0.0005535162,0.0004087817,0.001747924,0.0009218925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001490953,"about_ca_system_score_gemma":0.001765131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00169817,"about_ca_topic_score_gemma":0.004154503,"domain_scores_codex":[0.9991025,0.0004778288,0.00005039147,0.0001458504,0.00008337692,0.0001401707],"domain_scores_gemma":[0.9989235,0.0002250093,0.0003500802,0.00009509765,0.00008779851,0.0003185408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9412316,0.004025887,0.006147811,0.000797248,0.003694356,0.00007989583,0.00004078645,0.001803362,0.006092378,0.0001905729,0.00687377,0.02902233],"study_design_scores_gemma":[0.7696922,0.1706856,0.03830698,0.0001556824,0.004360871,0.0002594108,0.00003901852,0.002630476,0.003455359,0.0005148709,0.009843667,0.00005586374],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9517981,0.005507223,0.001451266,0.0009144592,0.000288565,0.009289254,0.0216808,0.0002871397,0.008783238],"genre_scores_gemma":[0.9732631,0.0009197386,0.001583405,0.001206008,0.0002231519,0.00455925,0.01249679,0.00005469219,0.005693847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007959607,"threshold_uncertainty_score":0.02662754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1747826780529209,"score_gpt":0.5093775652134046,"score_spread":0.3345948871604837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}